Otherwise, serious adverse events were reported in ~6% of participants and were evenly distributed across tirzepatide and placebo groups
For antihypertensive drugs like ACE inhibitors (lisinopril, ramipril), only minor changes in drug levels have been noted, which are generally not clinically significant
Participants treated with liraglutide (239), semaglutide (240), or tirzepatide (200) in the clinical trials had a percent reduction in fat mass approximately three times greater than the reduction in lean mass, leading to an overall improvement in body composition
Available from: Brittany V B Johnson 1 , Mary Milstead 1 , Rachel Kreider 1 , Rachel Jones 1 Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: A narrative review
This guide provides clear, step-by-step instructions aligned with UK clinical guidance to help you use your GLP-1 medication correctly
If injected in the same body region, ensure the injections are not next to each other
